mammary gland duct hyperplasia_Cav1<tm1Mls>/Cav1<tm1Mls>

http://metadb.riken.jp/0001885I129SvC57BL6SJLCav1tm1MlsCav1tm1MlsCav1tm1Mls

mammary gland duct hyperplasia_Cav1<tm1Mls>/Cav1<tm1Mls>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• caveolin 1, caveolae protein
  http://metadb.riken.jp/db/mgi_rdf/MGI:102709

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Cav1<tm1Mls>/Cav1<tm1Mls>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Cav1<tm1Mls>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129/Sv * C57BL/6 * SJL

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• mammary gland duct hyperplasia
  http://purl.obolibrary.org/obo/MP_0001885

文献

http://purl.org/net/cito/citesAsAuthority

• Hyangkyu. Lee, et.al., Caveolin-1 mutations (P132L and null) and the pathogenesis of breast cancer: caveolin-1 (P132L) behaves in a dominant-negative manner and caveolin-1 (-/-) null mice show mammary epithelial cell hyperplasia., The American journal of pathology, 2002, 161
  http://rdf.ncbi.nlm.nih.gov/pubmed/12368209